Page last updated: 2024-08-26

tretazicar and flucytosine

tretazicar has been researched along with flucytosine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chen, MJ; Chung-Faye, GA; Kerr, DJ; Searle, PF; Young, LS1
Brunicardi, FC; Fisher, WE; Yazawa, K1
Dachs, GU; Hunt, MA; Patterson, AV; Singleton, DC; Syddall, S1
Chang, D; Chang, HF; Chen, BM; Chen, SH; Chen, TC; Collins, S; Kasahara, N; Lin, SC; Lu, YC; Sun, JM; Tai, CK; Wang, HE; Wang, W; Wu, SF1

Reviews

3 review(s) available for tretazicar and flucytosine

ArticleYear
Gene therapy for colorectal cancer: therapeutic potential.
    BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 2001, Volume: 15, Issue:6

    Topics: Adenoviridae; Antigen Presentation; Aziridines; Carcinoembryonic Antigen; Clinical Trials as Topic; Colorectal Neoplasms; Flucytosine; Ganciclovir; Genes, p53; Genetic Therapy; Humans; T-Lymphocytes, Cytotoxic

2001
Current progress in suicide gene therapy for cancer.
    World journal of surgery, 2002, Volume: 26, Issue:7

    Topics: Animals; Antiviral Agents; Arabinonucleosides; Aziridines; Clinical Trials as Topic; Cytosine Deaminase; Escherichia coli; Flucytosine; Ganciclovir; Genetic Therapy; Genetic Vectors; Herpesvirus 3, Human; Humans; Neoplasms; Nitroreductases; Nucleoside Deaminases; Pentosyltransferases; Prodrugs; Purine Nucleosides; Simplexvirus; Thymidine Kinase; Xanthines

2002
Bystander or no bystander for gene directed enzyme prodrug therapy.
    Molecules (Basel, Switzerland), 2009, Nov-10, Volume: 14, Issue:11

    Topics: Animals; Aziridines; Cytosine Deaminase; Flucytosine; Ganciclovir; Genetic Therapy; Humans; Nitroreductases; Prodrugs; Thymidine Kinase

2009

Other Studies

2 other study(ies) available for tretazicar and flucytosine

ArticleYear
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model.
    International journal of molecular sciences, 2020, Feb-20, Volume: 21, Issue:4

    Topics: Animals; Aziridines; Brain Neoplasms; Cell Line, Tumor; Cytosine Deaminase; Escherichia coli Proteins; Flucytosine; Genetic Therapy; Genetic Vectors; Glioma; Leukemia Virus, Gibbon Ape; Neoplasms, Experimental; Nitroreductases; Prodrugs; Rats, Inbred F344; Saccharomyces cerevisiae Proteins

2020